share_log

藥明康德:自願公告 - 計劃受託人完成2024年H股獎勵信託計劃基本授予條件項下10億港元的H股股份購買

WUXI APPTEC: VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE ACQUISITION OF H SHARES BY THE SCHEME TRUSTEE IN THE AMOUNT OF HK$1 BILLION UNDER THE BASIC CONDITION OF GRANT OF THE 2024 H SHARE AWARD AND TRUST SCHEME

HKEX ·  Sep 24 06:40

Summary by Moomoo AI

药明康德(WUXI APPTEC)於2024年9月24日宣布,根據股東於2023年股東週年大會上批准的2024年H股獎勵信託計劃,計劃受託人已經使用不超過10億港元的資金通過市場內交易購買了27,478,428 H股,佔公司已發行股本總額的約0.94%。這些股份將用於激勵公司的核心員工,前提是公司在2024年實現的營業收入達到人民幣383億元或以上。該計劃的基本授予條件是否能達成仍存在不確定性,公司將按照適用法律法規及計劃規定執行相關計劃。
药明康德(WUXI APPTEC)於2024年9月24日宣布,根據股東於2023年股東週年大會上批准的2024年H股獎勵信託計劃,計劃受託人已經使用不超過10億港元的資金通過市場內交易購買了27,478,428 H股,佔公司已發行股本總額的約0.94%。這些股份將用於激勵公司的核心員工,前提是公司在2024年實現的營業收入達到人民幣383億元或以上。該計劃的基本授予條件是否能達成仍存在不確定性,公司將按照適用法律法規及計劃規定執行相關計劃。
WuXi AppTec announced on September 24, 2024 that, pursuant to the H Share Incentive Trust Plan approved by shareholders at the 2023 annual general meeting, the trustee has used up to 1 billion Hong Kong dollars to purchase 27,478,428 H Shares through on-market transactions, representing approximately 0.94% of the company's total issued share capital. These shares will be used to incentivize the company's core employees, provided that the company's revenue in 2024 reaches RMB 38.3 billion or above. Uncertainties remain regarding whether the basic grant conditions of the plan can be met, and the company will implement the relevant plan in accordance with applicable laws and plan provisions.
WuXi AppTec announced on September 24, 2024 that, pursuant to the H Share Incentive Trust Plan approved by shareholders at the 2023 annual general meeting, the trustee has used up to 1 billion Hong Kong dollars to purchase 27,478,428 H Shares through on-market transactions, representing approximately 0.94% of the company's total issued share capital. These shares will be used to incentivize the company's core employees, provided that the company's revenue in 2024 reaches RMB 38.3 billion or above. Uncertainties remain regarding whether the basic grant conditions of the plan can be met, and the company will implement the relevant plan in accordance with applicable laws and plan provisions.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more